Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Suneva Medical, Inc.
The Only Skin Care System With The Unique Multipotent Resignaling Complex (MRCx™)
SAN DIEGO, Aug. 7, 2014 /PRNewswire/ -- Suneva Medical, Inc., a privately-held aesthetics company, today announced that it has rebranded the popular Regenica® product line, an advanced skin care system formulated with the power of regenerative science and Multipotent Resignaling Complex (MRCx™) next generation growth factor technology. The newly refreshed line is comprised of three products, Regenica® Renew SPF 15, designed to protect skin from harmful UV rays while signaling skin's natural repair, Regenica® Replenishing Crème, to hydrate skin and reverse the signs of aging, and Regenica® Repair Complex, which helps accelerate skin renewal.
"Rooted in science and backed by years of advanced research, the new Regenica® look more accurately communicates its unique MRCx™ next generation growth factor formula," said Ava Shamban, MD, board-certified dermatologist and key investigator in the clinical research for Regenica®. "The line was carefully rebranded to help physicians attract patients to the power of growth factors, a key part of a balanced skin care regimen."
Featuring a sleek green and silver color palette, the refreshed Regenica® packaging closely aligns the brand's visual identity with its scientific foundation. Regenica's® MRCx™ next generation technology, made by a proprietary, patented process, is a rejuvenating blend of physiologically balanced growth factors that are naturally secreted by human fibroblasts. These fibroblasts have been conditioned to act like younger cells resulting in younger, fresher growth factors. Growth factors may stimulate tissue repair, regeneration and the production of collagen, elastin and extracellular matrix which makes Regenica® an ideal anti-aging skin care line for patients looking to better target the signs of aging. In a recent clinical study on Regenica®, more than 94 percent of women saw an improvement in skin texture, tone, firmness and the appearance of fine lines and wrinkles. Additionally, 100 percent indicated that they would recommend it to a friend.*
Regenica® is distributed by Suneva Medical and is exclusively dispensed through physician offices. It is available for purchase in dermatology, plastic surgery and other physician practices. Physicians interested in bringing Regenica® into their office should visit http://regenica.com/physician/. To find a physician who carries Regenica®, visit http://regenica.com/find-a-provider/.
Media interested in speaking with a Suneva Medical representative should contact Melody Demel at 619-234-0345 or email@example.com.
Regenica® and MRCx™ are trademarks of Suneva Medical, Inc.
About Suneva Medical, Inc.
Suneva Medical, Inc. is a privately-held aesthetics company focused on developing, manufacturing and commercializing novel, differentiated products for the general dermatology and aesthetic markets. The company currently markets ArteFill® in the U.S., Korea and Singapore; ReFissa® and Regenica® in the U.S. and Bellafill® in Canada. For more information, visit www.sunevamedical.com.
³data on file²
©2012 PR Newswire. All Rights Reserved.